Time to positivity of blood cultures of different Candida species causing fungaemia

Journal of Medical Microbiology

Volumn 61, Issue 5, 2012, Pages 701-704

  Lai, Chih Cheng ^a   Wang, Cheng Yi ^b   Liu, Wei Lun ^a   Huang, Yu Tsung ^c   Hsueh, Po Ren ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; CANDIDEMIA; FUNGAL DETECTION; FUNGEMIA; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; BLOOD; CANDIDA; CANDIDEMIA; FEMALE; HUMANS; MALE; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 84859825163     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.038166-0     Document Type: Article

References (28)

1. Abi-Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H. & Vartivarian, S. (1997). The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24, 1122-1128.
2. Almirante, B., Rodríguez, D., Park, B. J., Cuenca-Estrella, M., Planes, A. M., Almela, M., Mensa, J., Sanchez, F., Ayats, J. & other authors (2005). Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43, 1829-1835.
3. Asmundsdó ttir, L. R., Erlendsdóttir, H. & Gottfredsson, M. (2002). Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 40, 3489-3492.
4. Barnes, R. A. (2008). Early diagnosis of fungal infection in immunocompromised patients. J Antimicrob Chemother 61 (Suppl. 1), i3-i6.
5. Ben-Ami, R., Weinberger, M., Orni-Wasserlauff, R., Schwartz, D., Itzhaki, A., Lazarovitch, T., Bash, E., Aharoni, Y., Moroz, I. & Giladi, M. (2008). Time to blood culture positivity as a marker for catheterrelated candidemia. J Clin Microbiol 46, 2222-2226.
6. Blot, F., Schmidt, E., Nitenberg, G., Tancre de, C., Leclercq, B., Laplanche, A. & Andremont, A. (1998). Earlier positivity of centralvenous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 36, 105-109.
7. Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S. & Bearden, D. T. (2006). Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 43, 25-31.
8. Gherna, M. & Merz, W. G. (2009). Identification of Candida albicans and Candida glabrata within 1.5 hours directly from positive blood culture bottles with a shortened peptide nucleic acid fluorescence in situ hybridization protocol. J Clin Microbiol 47, 247-248.
9. Gumbo, T., Isada, C. M., Hall, G., Karafa, M. T. & Gordon, S. M. (1999). Candida glabrata fungemia. Clinical features of 139 patients. Medicine (Baltimore) 78, 220-227.
10. Horvath, L. L., George, B. J., Murray, C. K., Harrison, L. S. & Hospenthal, D. R. (2004). Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J Clin Microbiol 42, 115-118.
11. Hsiue, H. C., Huang, Y. T., Kuo, Y. L., Liao, C. H., Chang, T. C. & Hsueh, P. R. (2010). Rapid identification of fungal pathogens in positive blood cultures using oligonucleotide array hybridization. Clin Microbiol Infect 16, 493-500.
12. Khatib, R., Riederer, K., Saeed, S., Johnson, L. B., Fakih, M. G., Sharma, M., Tabriz, M. S. & Khosrovaneh, A. (2005). Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 41, 594-598.
13. Lai, C. C., Wang, C. Y., Liu, W. L., Huang, Y. T., Liao, C. H. & Hsueh, P. R. (2011). Time to positivity in blood cultures of staphylococci: clinical significance in bacteremia. J Infect 62, 249-251.
14. Leaw, S. N., Chang, H. C., Sun, H. F., Barton, R., Bouchara, J. P. & Chang, T. C. (2006). Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 44, 693-699.
15. Li, Y. L., Leaw, S. N., Chen, J. H., Chang, H. C. & Chang, T. C. (2003). Rapid identification of yeasts commonly found in positive blood cultures by amplification of the internal transcribed spacer regions 1 and 2. Eur J Clin Microbiol Infect Dis 22, 693-696.
16. Louie, R. F., Tang, Z., Albertson, T. E., Cohen, S., Tran, N. K. & Kost, G. J. (2008). Multiplex polymerase chain reaction detection enhancement of bacteremia and fungemia. Crit Care Med 36, 1487-1492.
17. Malani, A., Hmoud, J., Chiu, L., Carver, P. L., Bielaczyc, A. & Kauffman, C. A. (2005). Candida glabrata fungemia: experience in a tertiary care center. Clin Infect Dis 41, 975-981.
18. Morrell, M., Fraser, V. J. & Kollef, M. H. (2005). Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49, 3640-3645.
19. Orozco, A. S., Higginbotham, L. M., Hitchcock, C. A., Parkinson, T., Falconer, D., Ibrahim, A. S., Ghannoum, M. A. & Filler, S. G. (1998). Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chemother 42, 2645-2649.
20. Park, S. H., Shim, H., Yoon, N. S. & Kim, M. N. (2010). [Clinical relevance of time-to-positivity in BACTEC9240 blood culture system]. Korean J Lab Med 30, 276-283 (in Korean).
21. Parkinson, T., Falconer, D. J. & Hitchcock, C. A. (1995). Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 39, 1696-1699.
22. Patterson, T. F. (2005). Advances and challenges in management of invasive mycoses. Lancet 366, 1013-1025.
23. Pfaller, M. A. & Diekema, D. J. (2002). Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol 40, 3551-3557.
24. Ruan, S. Y. & Hsueh, P. R. (2009). Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 108, 443-451.
25. Ruan, S. Y., Lee, L. N., Jerng, J. S., Yu, C. J. & Hsueh, P. R. (2008). Candida glabrata fungaemia in intensive care units. Clin Microbiol Infect 14, 136-140.
26. Taur, Y., Cohen, N., Dubnow, S., Paskovaty, A. & Seo, S. K. (2010). Effect of antifungal therapy timing on mortality in cancer patients with candidemia. Antimicrob Agents Chemother 54, 184-190.
27. Wilson, A. G., Micek, S. T. & Ritchie, D. J. (2005). A retrospective evaluation of fluconazole for the treatment of Candida glabrata fungemia. Clin Ther 27, 1228-1237.
28. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. & Edmond, M. B. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39, 309-317.